Faraz M Ali

903 total citations
31 papers, 483 citations indexed

About

Faraz M Ali is a scholar working on Dermatology, Economics and Econometrics and Immunology. According to data from OpenAlex, Faraz M Ali has authored 31 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 12 papers in Economics and Econometrics and 8 papers in Immunology. Recurrent topics in Faraz M Ali's work include Dermatology and Skin Diseases (12 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). Faraz M Ali is often cited by papers focused on Dermatology and Skin Diseases (12 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). Faraz M Ali collaborates with scholars based in United Kingdom, South Africa and Canada. Faraz M Ali's co-authors include A.Y. Finlay, Sam Salek, Jui Vyas, John R Ingram, Vincent Piguet, Richard Kay, Florence Dalgard, Kennedy Otwombe, J. Küpfer and Nick Johns and has published in prestigious journals such as Journal of Investigative Dermatology, British Journal of Dermatology and Quality of Life Research.

In The Last Decade

Faraz M Ali

26 papers receiving 473 citations

Peers

Countries citing papers authored by Faraz M Ali

Since Specialization

Citations

This map shows the geographic impact of Faraz M Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faraz M Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faraz M Ali more than expected).

Fields of papers citing papers by Faraz M Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faraz M Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faraz M Ali. The network helps show where Faraz M Ali may publish in the future.

Co-authorship network of co-authors of Faraz M Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Faraz M Ali. A scholar is included among the top collaborators of Faraz M Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faraz M Ali. Faraz M Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple sclerosis greatly impacts family members/partners: Evidence using the Family Reported Outcome Measure (FROM-16) 2025 ·Multiple Sclerosis Journal - Experimental Translational and Clinical ·(unknown), Sam Salek, Faraz M Ali, Kennedy Otwombe, (unknown), Mark Nixon, Gillian Ingram, John R Ingram, A.Y. Finlay	0
2	P047 Dermatology Life Quality Index used as a standard in validation of 101 quality-of-life instruments: a systematic review 2024 ·British Journal of Dermatology ·Jui Vyas, Jeffrey Johns, (unknown), Faraz M Ali, John R Ingram, Sam Salek, A.Y. Finlay	0
3	Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study 2024 ·Diabetes Obesity and Metabolism ·(unknown), A.Y. Finlay, Faraz M Ali, Kennedy Otwombe, S J Nixon, Lindsay George, Marc Evans, John R Ingram, Sam Salek	1
4	Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross‐sectional study 2024 ·European Journal Of Haematology ·(unknown), A.Y. Finlay, Faraz M Ali, Harris Allen, S J Nixon, Mark Nixon, Kennedy Otwombe, John R Ingram, Sam Salek	4
5	Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values 2024 ·Quality of Life Research ·(unknown), Sam Salek, A.Y. Finlay, Richard Kay, S J Nixon, Kennedy Otwombe, Faraz M Ali, John R Ingram	5
6	The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review 2024 ·Journal of the European Academy of Dermatology and Venereology ·Jui Vyas, Jeffrey Johns, (unknown), Faraz M Ali, John R Ingram, Sam Salek, A.Y. Finlay	5
7	Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16) 2024 ·Journal of Patient-Reported Outcomes ·(unknown), A.Y. Finlay, Sam Salek, Harris Allen, S J Nixon, Mark Nixon, Kennedy Otwombe, Faraz M Ali, John R Ingram	7
8	A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index 2024 ·Acta Dermato Venereologica ·Jui Vyas, Jeffrey Johns, Faraz M Ali, John R Ingram, Sam Salek, A.Y. Finlay	3
9	Translation and validation of the Polish language version of the Teenagers Quality of Life questionnaire (T-QoL) 2023 ·Advances in Dermatology and Allergology ·(unknown), Piotr K. Krajewski, (unknown), (unknown), Faraz M Ali, A.Y. Finlay, Jacek C. Szepietowski	0
10	Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK 2023 ·BMJ Open ·(unknown), A.Y. Finlay, Sam Salek, (unknown), Kennedy Otwombe, Faraz M Ali, John R Ingram	8
11	A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries 2023 ·British Journal of Dermatology ·Jui Vyas, Jeffrey Johns, Faraz M Ali, (unknown), John R Ingram, Sam Salek, A.Y. Finlay	8
12	P82 Validation of the dermatology life quality index (DLQI): a systematic review of the literature 2023 ·British Journal of Dermatology ·Jeffrey Johns, Jui Vyas, Faraz M Ali, John R Ingram, Sam Salek, (unknown), A.Y. Finlay	1
13	Family reported outcomes, an unmet need in the management of a patient's disease: appraisal of the literature 2021 ·Health and Quality of Life Outcomes ·(unknown), Faraz M Ali, A.Y. Finlay, Sam Salek	20
14	Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey 2021 ·BMJ Open ·(unknown), Faraz M Ali, (unknown), John R Ingram, Sam Salek, A.Y. Finlay	72
15	The impact of psoriasis on quality of life of children and their caregivers: an Italian experience 2021 ·European Journal of Dermatology ·Federico Bardazzi, Marco Adriano Chessa, (unknown), Marica Iommi, Paola Rucci, Faraz M Ali, (unknown), (unknown), Iria Neri	1
16	Family Reported Outcome Measure – 16 (FROM-16): Creation, Reliability and Reproducibility of the Polish Language Version 2020 ·Acta Dermato Venereologica ·(unknown), Radomir Reszke, (unknown), Łukasz Matusiak, Faraz M Ali, A.Y. Finlay, Jacek C. Szepietowski	4
17	044 Validation of the electronic version of the Dermatology Life Quality Index (DLQI) 2017 ·Journal of Investigative Dermatology ·Faraz M Ali, Nick Johns, Sam Salek, A.Y. Finlay, Vincent Piguet	1
18	A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis 2016 ·British Journal of Dermatology ·Faraz M Ali, (unknown), Jui Vyas, (unknown), Sam Salek, A.Y. Finlay, Vincent Piguet	46
19	016 Ordinal logistic regression and Monte Carlo simulation in the mapping of DLQI scores to EQ-5D utility values 2016 ·Journal of Investigative Dermatology ·Faraz M Ali, Richard Kay, A.Y. Finlay, Vincent Piguet, J. Küpfer, Florence Dalgard, Sam Salek	3
20	Equivalence of electronic and paper-based patient-reported outcome measures 2015 ·Quality of Life Research ·(unknown), Faraz M Ali, A.Y. Finlay, Sam Salek	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact